Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report
View ORCID ProfileRaches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Samiran Panda, Priya Abraham, Nivedita Gupta, Krishna Ella, Balram Bhargava, Krishna Mohan Vadrevu
doi: https://doi.org/10.1101/2020.12.21.20248643
Raches Ella
1Bharat Biotech, Hyderabad, India
MBBS, MSSiddharth Reddy
1Bharat Biotech, Hyderabad, India
MScHarsh Jogdand
1Bharat Biotech, Hyderabad, India
PhDVamshi Sarangi
1Bharat Biotech, Hyderabad, India
BScBrunda Ganneru
1Bharat Biotech, Hyderabad, India
PhDSai Prasad
1Bharat Biotech, Hyderabad, India
MBADipankar Das
1Bharat Biotech, Hyderabad, India
PhDDugyala Raju
1Bharat Biotech, Hyderabad, India
PhDUsha Praturi
1Bharat Biotech, Hyderabad, India
MScGajanan Sapkal
2Indian Council of Medical Research-National Institute of Virology, Pune, India
PhDPragya Yadav
2Indian Council of Medical Research-National Institute of Virology, Pune, India
PhDPrabhakar Reddy
4Nizams Institute of Medical Sciences, Hyderabad, India
MDSavita Verma
5Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India
MDChandramani Singh
6All India Institute of Medical Sciences, Patna, India
MDSagar Vivek Redkar
7Redkar Hospital, Dargalim, India
MDChandra Sekhar Gillurkar
8Gillurkar Hospital, Nagpur, India
MDJitendra Singh Kushwaha
9Prakhar Hospital, Kanpur, India
MDSatyajit Mohapatra
10SRM Hospital and Research Centre, Kattankulathur, India
MDAmit Bhate
11Jeevan Rekha Hospital, Belgaum, India
MDSanjay Rai
12All India Institute of Medical Sciences, New Delhi, India
MDSamiran Panda
3Indian Council of Medical Research, New Delhi, India
MDPriya Abraham
2Indian Council of Medical Research-National Institute of Virology, Pune, India
PhDNivedita Gupta
3Indian Council of Medical Research, New Delhi, India
MDKrishna Ella
1Bharat Biotech, Hyderabad, India
PhDBalram Bhargava
3Indian Council of Medical Research, New Delhi, India
MDKrishna Mohan Vadrevu
1Bharat Biotech, Hyderabad, India
PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The study protocol is provided in the Supplemental Appendix Individual participant (de-identified) data will be made available when the trial is complete upon request directed to the corresponding author, after the approval of a proposal, data can be shared through a secure online platform.
Posted December 22, 2020.
Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report
Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Samiran Panda, Priya Abraham, Nivedita Gupta, Krishna Ella, Balram Bhargava, Krishna Mohan Vadrevu
medRxiv 2020.12.21.20248643; doi: https://doi.org/10.1101/2020.12.21.20248643
Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report
Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Samiran Panda, Priya Abraham, Nivedita Gupta, Krishna Ella, Balram Bhargava, Krishna Mohan Vadrevu
medRxiv 2020.12.21.20248643; doi: https://doi.org/10.1101/2020.12.21.20248643
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2621)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12163)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4054)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2617)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (840)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3824)
- Nursing (208)
- Nutrition (569)
- Oncology (2004)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1107)
- Primary Care Research (445)
- Public and Global Health (6495)
- Radiology and Imaging (1385)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)